If you have been reading about GLP-1 analog and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-05-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.
Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.
Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Batch-to-batch variation is normal |
| Solubility class | Soluble in water, buffer, and dimethyl sulfoxide | Aqueous solubility is moderate |
| Typical storage temperature | Minus 20 degrees Celsius dry, 2 to 8 degrees Celsius reconstituted | Avoid repeated freeze-thaw |
| Common analytical method | Reverse-phase HPLC with electrospray mass detection | Used for purity and mass confirmation |
| Common synonyms | GLP-1 analog, semaglutide peptide | Wording varies across suppliers |
Storage at minus 20 degrees Celsius or lower in a desiccated container preserves the peptide for extended periods, while working solutions are commonly held at two to eight degrees Celsius for short intervals. Light exposure and repeated freeze-thaw cycles accelerate degradation, so dividing material into single-use aliquots is generally recommended. Adsorption to glass and plastic surfaces can lower the measured concentration of dilute solutions, particularly below one milligram per millilitre. The degradation routes most often reported for GLP-1 analogues are deamidation, methionine oxidation, and backbone hydrolysis. Relative rates under specific conditions are frequently described only for individual formulations.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 or 280 nanometres is widely used to assess purity and to resolve related impurities. Liquid chromatography coupled to mass spectrometry confirms identity through the protonated molecular ion and fragment ions formed in tandem experiments. Capillary electrophoresis and peptide mapping after enzymatic digestion supply complementary information on charge variants and modification sites. Circular dichroism and nuclear magnetic resonance can report on secondary structure in solution. Absolute quantification usually depends on an external standard, and reported purity depends on the detection wavelength and integration parameters chosen.
Handling practices center on minimizing contamination and adsorption. Lyophilized peptide tends to accumulate static charge, so weighing is done with antistatic measures and calibrated balances. Reconstitution with appropriate solvent should be gentle, avoiding vigorous vortexing that generates foam and shear. Solutions are typically aliquoted before freezing to reduce repeated temperature cycling. Personal protective equipment and a fume hood are standard for powder handling.
Reconstituted solutions are less stable than the dry powder, and stability depends on concentration, pH, buffer composition, and container material. Low-protein-binding tubes reduce loss of peptide to plastic surfaces. Some researchers add a carrier protein to limit adsorption at low concentrations. The exact shelf life of a given solution is best determined empirically through a stability study rather than assumed from general guidance, because published data cover only a limited set of conditions.
Storage conditions for semaglutide depend heavily on the presentation. Lyophilized research powder is generally kept at two to eight degrees Celsius in a sealed container, protected from light and moisture. Manufacturer labeling for finished injectable products specifies refrigeration before first use, with defined in-use periods at room temperature afterward. The oral tablet form is stored at controlled room temperature and is more tolerant of short excursions. Temperature excursions should be documented rather than inferred.
The sequence incorporates alpha-aminoisobutyric acid at position 8, replacing the alanine found in the natural hormone. This substitution blocks the primary DPP-4 recognition site and contributes most of the enzymatic stability. Albumin binding further protects the peptide and reduces the frequency of administration required to maintain active plasma levels. Because the fatty acid chain increases lipophilicity, the compound is formulated as a solution rather than a simple aqueous buffer. Researchers describe the design as an incremental optimization of earlier GLP-1 analogs rather than a wholly new scaffold.
Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
== Classification == This mushroom has been placed in the section Aztecorum by Gaston Guzman; other members of the section include Psilocybe aztecorum var. aztecorum, Psilocybe aztecorum var. bonetii, Psilocybe pseudoaztecorum, and Psilocybe quebecensis.
=== 2000 === 13 March The Secret Life of the Crash Test Dummy, about the biomechanics of car crashes; a typical crash test dummy cost around £100,000, with about three hundred individual parts, that had to be included by safety law, and new cars could not be sold until the dummy had tested it sufficiently; the Volvo 300 1980s television advert; Lt-Col Wayne Mattson of the USAF and a strange crash in New Mexico, one hundred miles north of the Trinity (nuclear test), and near White Sands Missile Range, where German V-2 missiles were being tested, which were conveniently blamed by the USAF on anthropomorphic dummies; John Melvin (engineer) and the legacy of USAF biophysicist and doctor Colonel John Stapp, who mostly invented aviation safety testing; John Stapp conducted gruesome horrific deceleration tests on himself; Alderson had made artificial limbs for injured USAF World War II pilots, so made a full artificial proto-human; John Stapp tested his dummies in vehicles; Clarence Ditlow and the Center for Auto Safety; in 1966 it became legal in the US for new cars to have been tested by dummies; mathematical models of injury were needed, to translate the acquired crash data into possible effects on the human body, worked out by mechanical engineer Walter Pilkey of the University of Virginia; Scottish orthopaedic surgeon Angus Wallace and impact speed on bone tensile strength; in 1976 the Hybrid III dummy was designed, the automotive industry standard design; David Abbott, advertising executive; the data for designing the crash test dummy, Hybrid III, was mostly derived from data procured for human male occupants - and typical (fiftieth percentile) males, not female, and females had much different bodies; child dummies were essentially smaller adult male dummies, which was not biologically true; new dummies were developed at the National Transportation Biomechanics Research Center. Narrated by Andrew Lincoln, produced by Cathy Rogers, directed by Peter Webber, made by RDF Television. Shown on Wednesday 17 January 2001 on The Nature of Things in Canada 20 March Rise and Fall of GM Food, about genetically modified food; Belgian geneticist Marc Van Montagu, of the University of Ghent, visits Havana in Cuba, where a new research centre opened with Carlos Borroto; protests by topless women; GM was largely first developed by Mexican geneticist Herrera Estrella, of the Centre of Investigation and Advanced Studies; Rob Fraley of Monsanto; US farmers spend $8bn dollars on herbicides and pesticides; Roger N. Beachy had a breakthrough in 1986 at the Washington University in St. Louis, now at the Donald Danforth Plant and Science Center; Monsanto made the first insecticide-resistant plant in 1987; many African farmers cannot afford insecticides; Cyrus Ndiritu of the Kenya Agriculture Research Institute; much food harvested in Africa does not last before it reaches the consumer; in 1990 Don Grierson of the Plant Science Division of the University of Nottingham found genes of ripening; Channapatna Prakash of Tuskegee University in Alabama; aluminium toxicity of soils in tropical countries affected yield; Julian Borger of The Guardian; biologist Mae-Wan Ho of the Open University; biologist John Gatehouse of the University of Durham, and the Pusztai affair at The Rowett Institute; Helen Browning, Chairman of the Soil Association; former Vice-Chancellor of UEA, Derek Burke; former Independent environment correspondent Richard D. North, who had grown out of love with the hard-line environmental movement; European farmers grew five times more produce than they did in the 1960s, and there were twice as many trees in the UK than in the 1920s; Renée Elliott of Planet Organic; around 100m children in Third World countries suffered from Vitamin A deficiency. Directed by Martin Durkin, made by his company Kugelblitz 27 March Simply Complex, about the physicist Murray Gell-Mann; by an accident, he devised strangeness of sub-atomic particles, in his mid-20s; he predicts an omega minus particle, which was found in 1962; he predicts that the proton and neutron were made of three triplet particles, which he called quarks from Finnegans Wake and his Eightfold way (physics), also predicted by George Zweig; he worked closely with Richard Feynman at Caltech in the 1960s; on 30 October 1969 he is told that he had won the Nobel Prize for Physics; his friendship with MIT mechanical engineer Seth Lloyd; British physicist Geoffrey West; the documentary is in a biographic informal style that Horizon has since often followed. Produced by Barbara Altounyan, directed by Celia Lowenstein, made by Diverse Productions 3 April Meningitis - Search for a Cure, 3,000 people in the UK had meningitis in 1999; microbiologist Martin C. J. Maiden; one in five died from meningococcal disease; damage is caused by the endotoxin (lipopolysaccharide); a healthy survey is carried out at Burford School; Mike Levin (paediatrician) at Imperial College, and how meningitis A is a huge danger in Africa; 60% of cases in the UK are meningitis B, and many such cases are treated at St Mary's Hospital, London; Brett Giroir of the Children's Medical Center Dallas; 17-year-old Amy Mansell from Whitstable was in a coma for five weeks. Narrated by Paul Brightwell, produced by David Dugan, directed by Jeremy Llewellyn-Jones, made by Windfall Films with Nova and WGBH Boston. It was shown on Nova as Killer Disease on Campus, episode 9 of season 29, shown on 3 September 2002, and shown under the original programme title as a half-hour programme on 6 November 2003 on Catalyst on ABC in Australia 10 April The Box, about flight recorders, with ValuJet Airlines Flight 592 which crashed on 11 May 1996; voice recorders have been compulsory since the late 1960s; Dukane Seacom make emergency underwater locator beacons (ULBs); the Boeing 737, which had around 21,000 take-offs per day, was believed to have unreliable rudder control since the 1980s, as shown in the United Airlines Flight 585 crash on 3 March 1991, having had two rudder incidents in the previous two weeks, with the aircraft flipping 35 seconds after take-off and crashing all in seven seconds; the electrohydraulic servo valve in the Boeing 737 rudder control unit was thought to be sometimes temperamental; Boeing claimed that the March 1991 crash was due to a rotor or lee wave, caused by nearby mountains; the USAir Flight 427 crash on 8 September 1994, where the aircraft flipped at 6,000 ft, in 28 seconds crashing; British Airways did not rely on their Penny & Giles quick access recorders, and would consolidate this data where anomalies were checked, so the NTSB needed BA's data for their 737 aircraft; this safer BA method was introduced by the previous British European Airways (BEA) when it had to prove to the CAA that its autoland system for the Trident was safe, in the Civil Aircraft Airworthiness Data Recording Programme which since 1990 has been collected by the British Airways Safety Information System (BASIS); the 1991 crash investigation concluded after 8 years in 1999, with Boeing ordered to redesign the servo valve. 9 October Full Throttle, about the technology and psychology of motor racing; Brazilian driver Christian Fittipaldi; the Eurofighter, controlled by computers, and due to enter RAF service in 2002; Archie Neill, BAE test pilot; Stephen Olvey, motor racing medical officer; driver Mark Blundell; the Long Beach Grand Prix in Los Angeles; Steve Clark, engineer for Mercedes; Brian Lisles and Peter Gibbons of Newman Haas Racing; the edge of performance envelope; Mario Andretti, former driver: Edward Winter of Sheffield Hallam University and predicting outcomes in sport, by intuition; John Rothwell of the Institute of Neurology in London, testing reflexes, by an MRI scanner, and how the brain stores instructions; psychologist Mike Land of the University of Sussex, and the psychology of prediction, and feedforward; life expectancy of racing drivers in the 1970s was short; racing drivers had risk positive personalities, and became accustomed to risk; psychologist Tim Wheeler; Jimmy Vasser of Chip Ganassi Racing; a female violinist plays La fille aux cheveux de lin; sports psychologist Brian Hemmings; Austrian driver Alexander Wurz of Benetton Formula; RAF SEPECAT Jaguar XZ103 of 41 Squadron; engineer Pat Symonds of Benetton Racing; Simon Taylor (journalist) of Motor Sport; Graham Rood of DERA Air Systems in north Hampshire. Narrated by Stephen Rashbrook, produced by Patrick Uden, directed by Andy Robbins, made by Uden Associates 16 October Lethal Seas: the Maelstrom, about ocean whirlpools; the Gulf of Corryvreckan in Scotland, Lofoten and Saltstraumen in Norway; with Prof Tsukasa Nishimura of Tokyo University of Science and Prof Walter Munk of the Scripps Institution of Oceanography; the Firth of Lorn in west Scotland has one of the world's most dangerous whirlpools, the Royal Navy avoids it; atmospheric physicist Peter Read; mathematician David Dritschel, and the Great Red Spot vortice; the dangerous Arran Rapids on the Cordero Channel in western Canada; Burkard Baschek of the Institute of Ocean Sciences, who dropped a CTD (instrument) into the torrential river currents; Tremble Island in the notorious Slingsby Channel, where a geophone was placed; the novel A Descent into the Maelström; Bjørn Gjevik, a fluid dynamicist in the Department of Mathematics, at the University of Oslo; strong tidal currents in the Naruto Strait in Japan, and the Naruto whirlpools. Narrated by Stephen Rashbrook, produced by Robert Sproul-Cran, directed by Kim Flitcroft, made by Northlight Productions with the Discovery Channel 23 October Einstein's Biggest Blunder, about calculations of the expansion of the universe; the documentary opens with a pastiche of the Star Wars opening credits; two physicists met in 1996, with a new radical proposal for explaining the many anomalies in the expansion of the universe - Andreas Albrecht (cosmologist) of the University of California, Davis and João Magueijo of Portugal; Dave Wark of the University of Sussex, visits Bern in Switzerland; Ruth Durrer of the University of Geneva; John E. Baldwin of the University of Cambridge, and the 1887 Michelson–Morley experiment, which found that the Earth's rotational speed did not affect the speed of light in any way, alongside the Venus movement of The Planets; to account for this, Einstein made his field equations, and lambda - the cosmological constant was added by Einstein to account for how space-time would need to expand; Einstein's equations inferred that the expansion of the universe rested on inherently unstable conditions; due to the Doppler effect, background radiation from the Big Bang is now perceived as microwave radiation; Richard Ellis (astronomer) of Caltech; Einstein didn't believe in the Big Bang until a meeting with Hubble in 1932 in California; with the new theory of an expanding universe, the cosmological constant was now required, but the precise trajectory of the expansion of the universe could not be directly predicted, which led to the flatness problem; the theory of inflation was put forward by Alan Guth in the 1970s; when at St John's College, Cambridge, João Magueijo had the radical proposal that if the speed of light was higher, in the early universe, a cosmological horizon of sufficient distance would be possible, to explain the predicted conditions of the expansion of the early universe, and the cosmological constant problem; the Royal Society gave him a research fellowship to work at Imperial College; as further exploratory work was clocked up, with calculations inclya variable speed of light, the team of physicists looked at other applications for their controversial proposals, such as the flatness problem, and what happened before the Big Bang; in 1998 astrophysicist John Webb, at the University of Cambridge, worked on the theory of a variable speed of light, through investigating quasars, the most distant objects that can be seen; and by looking at supernovae, it was largely expected that any recorded data would show indications of a deceleration in the rate of expansion of the universe, but the data instead showed that the rate of expansion was - increasing, which led to the lambda-CDM model. Narrated by Scottish actor Matthew Zajac, directed by David Sington, made by Dox Productions 30 October The Science of Stress, with 42-year-old actor Angus Kennedy; endocrinologist Stafford Lightman of the University of Bristol; Vivette Glover, a perinatal psychobiological at Imperial College; Sir Cary Cooper, psychologist at the former UMIST; Carolyn M. Mazure, psychiatrist at Yale School of Medicine; Charles Nemeroff, psychiatrist at Emory University School of Medicine. Narrated by Geoffrey Palmer, directed by Michael Samuels, produced by Bridget Sneyd, made by Lion Television and the Discovery Health Channel 7 December Science of Crime - Psychopath, with psychologists Robert D. Hare and Adrian Raine, about the psychopathic traits of insincere superficial charm, on the Psychopathy Checklist. Narrated by Neil Pearson, directed by John Purdie, produced by Rosalind Arden, made by Union Pictures 14 December Science of Crime - Criminal Evidence, about the forensic psychologist 49-year-old Kathy Reichs. Produced by Geoff Deehan, directed by Roger Pyke, made by Yap Films 21 December Science of Crime - Cybercops, the Hackers on Planet Earth conference; Cult of the Dead Cow, founded by Swamp Rat, and its Back Orifice software for accessing Windows 98; the Happy99 virus; wardialing; part of the High Technology Theft Apprehension and Prosecution Program in California. Narrated by Steven Mackintosh, written by Callum Macrae, directed by Witold Starecki
== Uses == Proline and its derivatives are often used as asymmetric catalysts in proline organocatalysis reactions. The CBS reduction and proline catalysed aldol condensation are prominent examples. In brewing, proteins rich in proline combine with polyphenols to produce haze (turbidity). L-Proline is an osmoprotectant and therefore is used in many pharmaceutical and biotechnological applications. The growth medium used in plant tissue culture may be supplemented with proline. This can increase growth, perhaps because it helps the plant tolerate the stresses of tissue culture. For proline's role in the stress response of plants, see § Biological activity.
Sources: en.wikipedia.org
In 2007, Hetero commissioned and established Asia’s largest Special Economic Zone (SEZ) for API manufacturing in Visakhapatnam, Visakhapatnam district Andhra Pradesh. The scale of the infrastructure provided by the complex enabled Hetero to pursue its ambitions as a global bulk pharmaceutical supplier.
== Early life and education == Born in Berlin, to a Jewish family, his family home was located on Reichskanzlerplatz, renamed “Adolf Hitler Platz” after Hitler's ascent to power, and then Theodor Heuss Platz after the Second World War. Both of his parents (Alfred and Kaethe, née Italiener) were physicians. His mother, a pediatrician, was in pre-war times the physician to Harald Quandt, son of Magda Quandt née Rietschel, later Magda Goebbels, wife of the German propaganda minister. The second of three children, Beutler was preceded by an older brother, Frederick (b. October 3, 1926, later a professor of mathematics at the University of Michigan), and followed by a younger sister, Ruth (b. November 23, 1932, later a clinical psychologist; d. July 14, 1993). In 1935, when Beutler was seven years of age, the family emigrated to the United States to escape Nazi persecution. Beutler was raised in Milwaukee, Wisconsin. At 15, Beutler enrolled in a special program at the University of Chicago, founded by Robert Hutchins, then President of the University. He completed his undergraduate, medical school and residency training at the University of Chicago, receiving his doctorate in medicine in 1950 at the age of 21. He was a member of Pi Lambda Phi and the valedictorian of his graduating class.
Since the discovery and synthesis of testosterone in the 1930s, AAS have been used by physicians for many purposes, with varying degrees of success. These can broadly be grouped into anabolic, androgenic, and other uses.
"One strain isolated from tissue debrided from a compound fracture of the tibia was particularly active. We named this growth-antagonistic strain for the patient, Tracy I. When cell-free filtrates of broth cultures of this bacillus proved to possess strong antibiotic activity and to be non-toxic, further study seemed warranted. We have called this active principle 'bacitracin'." Bacitracin was approved by the US FDA in 1948.
Sources: en.wikipedia.org
Manufacturers commonly state multi-year stability when the powder is kept dry and frozen. Actual shelf life depends on residual moisture, vial sealing, and storage temperature. A re-test by chromatography is the only way to confirm remaining purity.
Deamidated and oxidized forms are the most frequently reported impurities. Truncated peptide fragments from incomplete synthesis also appear at low levels. Their relative abundance grows with time, heat exposure, and unfavorable pH.
Retention time matching on a validated column provides strong circumstantial evidence. It does not distinguish compounds with similar hydrophobicity. Mass measurement or peptide mapping is needed for unambiguous identification.
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.